Travel & financial grants

The Assistance Fund

The Uveitis Copay Assistance Program provides financial assistance for out-of-pocket costs, including copays, deductibles, and coinsurance, for FDA-approved uveitis treatments. To qualify, patients must be U.S. citizens or permanent residents diagnosed with uveitis, prescribed an FDA-approved treatment, have prescription coverage, and meet financial eligibility criteria based on household income and size. The program is currently accepting patients to its waitlist.

Taiho Oncology

The Taiho Oncology Patient Assistance Program is a grant to assist patients. Specific details regarding coverage types, eligibility, and application status are unknown as the provided document is a non-extractable PDF.

The provided page content is extremely sparse and only identifies the official patient website for TALVEY. It does not contain any information regarding grant coverage, eligibility criteria, application process, or the sponsoring organization for the TALVEY Savings Support program.

Janssen

Information regarding the Tarpeyo Touchpoints grant, including its coverage, eligibility, and application details, could not be found within the provided page content. The page lists general prescription discount and assistance resources from the National Kidney Foundation, but does not mention this specific grant by name.

Novartis Oncology

The Tasigna Co-Pay Assistance Discount Card program is offered by Novartis Oncology to provide co-pay assistance. It is available for commercially insured patients who are taking Tasigna (Nilotinib). The National CML Society can assist patients with the application process for this program.

Biogen

This page provides information about the TECFIDERA drug, its side effects, and tools for managing treatment. While the URL suggests financial support, the provided content primarily discusses general patient resources and does not detail any travel assistance grant, its coverage, or eligibility requirements.

TECVAYLI

The TECVAYLI Community Support page serves as a directory for Multiple Myeloma patients and their care partners, listing various external organizations that provide educational, emotional, and practical support. While TECVAYLI itself does not offer direct financial or travel assistance through this program, it guides users to resources like the American Cancer Society that can assist with lodging and transportation needs.

TerSera

TerSera offers co-pay assistance for the prescription medication Xermelo (telotristat ethyl). This program is designed for adults with carcinoid syndrome diarrhea who are using Xermelo along with somatostatin analog (SSA) therapy, especially when their condition is not adequately controlled by SSA therapy alone.

The Assistance Fund

The Assistance Fund provides financial assistance for patients facing high medical out-of-pocket costs, including copayments, coinsurance, and deductibles, for FDA-approved treatments of specific retinal diseases. Eligibility requires U.S. citizenship or permanent residency, a confirmed diagnosis, prescription coverage, and meeting financial criteria based on household income and size.

The Assistance Fund

The Neuromyelitis Optica Spectrum Disorder Financial Assistance Program, offered by The Assistance Fund, provides financial aid for out-of-pocket costs including prescription drug assistance, health insurance premiums, therapy administration, and travel costs (ground transport, air, meals, hotel) to treatment centers or physicians. Eligibility requires being a U.S. citizen/permanent resident, diagnosed with the disease, prescribed an FDA-approved treatment with prescription coverage, and meeting financial criteria based on household income and size. The program is currently open for new patient enrollments.

The Assistance Fund

The Assistance Fund's Sickle Cell Disease Financial Assistance Program offers grants for ground travel costs to a treatment center for FDA-approved treatments, as well as other out-of-pocket medical expenses. Eligible patients must be U.S. citizens or permanent residents diagnosed with Sickle Cell Disease, have prescription coverage, and meet financial eligibility criteria based on household income and size. The program is currently on a waitlist.

The Assistance Fund

The Paroxysmal Nocturnal Hemoglobinuria Financial Assistance Program helps eligible U.S. citizens or permanent residents with FDA-approved treatment for PNH. It covers copays, coinsurance, deductibles, health insurance premiums, therapy administration costs, and travel expenses including ground transportation, airfare, meals, and hotel stays to treatment centers or specialists. Eligibility is based on household income and size.

The Assistance Fund

The Uveitis Copay Assistance Program, sponsored by The Assistance Fund, provides financial assistance for out-of-pocket costs for prescribed FDA-approved Uveitis treatments, including copays, deductibles, and coinsurance. Eligible patients must be U.S. citizens or permanent residents diagnosed with Uveitis, have prescription coverage, and meet financial eligibility criteria based on household income and size. The program is currently accepting patients for its waitlist.

The Assistance Fund

The Assistance Fund's Fabry Disease Financial Assistance Program provides grants to eligible U.S. citizens or permanent residents diagnosed with Fabry disease who are prescribed an FDA-approved treatment and meet financial criteria based on household income and size. The program covers prescription drug costs, health insurance premiums, therapy administration, genetic testing, and travel expenses including ground transportation, air travel, meals, and hotel stays for treatment-related appointments.

The Assistance Fund

The Immunoglobulin A Nephropathy (IgAN) Financial Assistance Program provides financial assistance for out-of-pocket medical costs, including prescription drugs, health insurance premiums, therapy administration, and travel expenses for treatment or specialist visits. Covered travel includes airfare, ground transportation, lodging, and meals. Eligibility requires U.S. citizenship or permanent residency, a diagnosis of IgAN, a prescribed FDA-approved treatment with prescription coverage, and meeting financial eligibility criteria based on household income and size.

The Assistance Fund (TAF)

This grant, provided by The Assistance Fund (TAF), offers financial assistance for copays, deductibles, and coinsurance for FDA-approved psoriasis treatments. It is available to commercially insured and Medicare/Medicaid patients residing in the US and Puerto Rico who meet income eligibility requirements.

The Life Raft Group

The Life Raft Group's financial aid page serves as a resource, listing patient assistance programs from other organizations, not detailing a direct grant from The Life Raft Group itself. The primary financial assistance mentioned is from The Sarcoma Alliance for second opinions, offering up to $1000 for consultations for US residents. Other programs listed focus on medication co-pay and discount assistance, with no explicit travel coverage mentioned.

Merck